Gloria Melanie 4

4 · Immunovant, Inc. · Filed Apr 10, 2026

AI-generated summary of this filing

Updated Apr 10, 2026

Immunovant (IMVT) COO Gloria Melanie Sells 8,722 Shares

What Happened

Gloria Melanie, Chief Operating Officer of Immunovant (IMVT), sold 8,722 shares on April 8, 2026 in open-market transactions for a total of approximately $216,567. The filing reports a weighted-average price of $24.83 per share (individual sale prices ranged $24.54–$25.39). This was a sale (not a purchase) and appears to be a routine tax-withholding sale tied to RSU vesting rather than a discretionary market-timing trade.

Key Details

Transaction date(s): April 8, 2026; Form 4 filed April 10, 2026 (appears timely).
Price: Weighted average $24.83; individual prices ranged $24.54–$25.39 (per footnote F2).
Shares sold: 8,722; total proceeds ≈ $216,567.
Shares owned after transaction: Not specified in the supplied excerpt of the filing.
Notable footnotes:
- F1: These shares were sold to satisfy tax withholding upon settlement of RSUs. The reporting person received 76,181 RSUs on April 1, 2025, of which 19,045 vested on April 1, 2026. The issuer elected a mandatory "sell to cover" for tax obligations, so the sale was not a discretionary trade.
- F2: Price is a weighted average; full breakdown of shares sold at each price is available on request (per footnote).
Filing timeliness: Filed April 10 for an April 8 transaction — within the typical two-business-day Form 4 window.

Context

This was a sell-to-cover tied to RSU vesting (a common administrative sale to cover taxes). Such sales generally do not signal the insider’s view on company prospects in the same way that voluntary open-market purchases might.

Form 4

Period: 2026-04-08

Chief Operating Officer

Transactions

Footnotes (2)

[F1]On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Signature

/s/ Tiago Girao, attorney-in-fact for Melanie Gloria|2026-04-10

1 file